viernes, 13 de noviembre de 2026
BuscarExplore

Meta Cuts 10% of Reality Labs, Shuts Down Multiple VR Gaming Studios

Meta cuts 10% of Reality Labs, closing VR gaming studios like Twisted Pixel and Sanzaru, signaling a shift in metaverse investments.

Meta Cuts 10% of Reality Labs, Shuts Down Multiple VR Gaming Studios
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Meta is cutting about 10 percent of its Reality Labs metaverse division, including shutting down several virtual reality (VR) gaming studios, according to The Verge AI. This move signals a significant shift in Meta’s strategic investments in the metaverse, a term used to describe immersive digital environments where users can interact virtually.

The closures affect Twisted Pixel Games, known for developing Marvel’s Deadpool VR, and Sanzaru Games, the creator of the Asgard’s Wrath series. Additionally, Armature Studio, responsible for the Resident Evil 4 VR port, will also cease operations. These studio closures represent a substantial setback for Meta’s ambitions in the VR gaming space, which once included high-profile acquisitions of these studios in recent years.

According to The Verge AI, Meta spokesperson Tracy Clayton confirmed that the team behind the VR fitness app Supernatural will no longer develop new content or features for it, although existing support will continue. The closures have left many developers without jobs, as evidenced by posts on social media platforms. Former Twisted Pixel level designer Andy Gentile shared, “It appears the entire Twisted Pixel Games studio has been shut down along with Sanzaru and Armature too.”

This downsizing follows Meta’s previous closure of Echo VR developer Ready at Dawn in 2024, another studio acquired in 2020. In a statement about the broader Reality Labs layoffs, Clayton noted that the company was “shifting some of our investment focus.” The future direction of Meta’s metaverse efforts remains uncertain, but the recent layoffs suggest a period of reassessment and realignment for the tech giant.

Despite the current retrenchment, Meta’s long-term commitment to the metaverse is still expected to continue, albeit with a more streamlined approach. The exact implications for Meta’s future projects in the space remain to be seen.

As the tech industry continues to navigate economic challenges and evolving consumer preferences, Meta’s decision underscores the competitive and volatile nature of the metaverse sector. The outlook for Meta’s metaverse initiatives suggests a period of consolidation and reevaluation.

In the wake of these layoffs, the VR gaming community is grappling with the impact of these changes, while also keeping an eye on how Meta will proceed with its remaining projects and investments in the metaverse. The broader industry will likely watch closely to see if other major players follow suit in scaling back their metaverse ambitions.

This restructuring comes as Meta faces increased scrutiny and pressure to demonstrate the commercial viability of its metaverse projects. The company’s recent moves indicate a recalibration of its approach to ensure sustainability and alignment with market demands.

The future of VR gaming and the metaverse at large remains uncertain, but Meta’s actions signal a pivotal moment in the development of immersive technologies. The company’s next steps will be closely monitored by both industry insiders and consumers alike.

While the immediate impact is a reduction in workforce and operational scope, the long-term effects on Meta’s metaverse strategy and the broader industry remain to be seen. The outlook for Meta’s future projects in the metaverse is one of cautious optimism amid ongoing adjustments.

This restructuring highlights the evolving landscape of the metaverse, with companies like Meta navigating the challenges of creating sustainable, engaging virtual environments. The future direction of Meta’s metaverse efforts will depend on how effectively it can adapt to changing market conditions and technological advancements.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s met

In this story · Archivos de Conocimiento

Equipo Editorial de Via News
Equipo Editorial de Via News

El equipo editorial de Via News rastrea cómo la IA transforma los mercados, el capital y el trabajo — cada afirmación trazada a su fuente.

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com